The firm's chemical strategy can be applied broadly to most targets in therapeutic areas, targets such as:
-protein:protein interactions (PPI)
-antibacterial targets
-ubiquitin ligases
-epigenetic targets
-GPCRs
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze